Clinical Trial Update: Capecitabine and Pegylated Interferon Alfa-2a in Treating Patients With Recurrent or Progressive Brain Metastases Due to Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of capecitabine plus pegylated interferon alfa-2a in patients with recurrent or progressive brain metastases from breast cancer was termi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Pegylated interferon alfa-2a (Peginterferon alfa-2a)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Breast Cancer, Metastatic Cancer | Phase 2 | Status: TERMINATED